NCT06735950 The Volunteering-in-Place Program for Apathetic Assisted Living Residents With ADRD
| NCT ID | NCT06735950 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Maryland, Baltimore |
| Condition | Apathy in Dementia |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2026-10-01 |
| Primary Completion | 2027-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2026-10-01 with a primary completion date of 2027-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a research study to test two different interventions to decrease apathy in assisted living residents with some memory issues. Apathy makes older adults not feel like doing much activity. This study is completely voluntary and will not affect the care you receive at your assisted living community. The two possible interventions are 1) participation in a volunteering opportunity within the assisted living community OR 2) participation in a guided current events group within the assisted living community. These activities would be in addition to any other regular activities you participate in within the assisted living community. Both activities would take place three days per week for approximately 30 minutes. You would be randomly assigned (like a coin flip) to which intervention you would do. You do not get to choose. You would participate in the activity for a total of 6 months. In addition to participating in the intervention (either volunteering or current events), you will be asked to answer some questions about your memory, level of activity, mood, confidence in your ability to do a volunteer job, and feelings of usefulness. You will answer these questions at baseline (before the activity begins, at 3 months after doing the intervention activity, and aging at 6 months after starting the interventions activity. You will also be asked to wear a MotionWatch for 5 days at each time point (baseline, 3months and 6 months). A motion watch measures your level of activity. It feels like wearing a regular watch. You will be in the study for 6 months total. Risks to participating in this study are minimal and include privacy (other people may find out you are in the study), confidentiality of the data collected if someone other than study staff accesses your records, fatigue with answering the questionnaires, and some mild discomfort with wearing the MotionWatch. This is also a minor risk that you could fall or otherwise harm yourself getting to or participating in your intervention activity. The benefit of participating in this study include possible enjoyment of participating in the intervention activity.
Eligibility Criteria
Inclusion Criteria: * age 55 years or older; * English speaking; * live in the included AL community * have mild to moderate cognitive impairment based on a SLUMS score of 26 or below and the ability to follow a one-step command. * have apathy based on a "yes" answer to at least 2 questions on the apathy subscale of the Neuropsychiatric Inventory (NPI) completed by a family or staff member who has had close contact with the resident in the past month; * have an anticipated length of stay of 12 months. Exclusion Criteria: \- refusal to assent
Contact & Investigator
Jennifer Klinedinst, PhD, MPH, RN
PRINCIPAL INVESTIGATOR
University of Maryland, Baltimore
Frequently Asked Questions
Who can join the NCT06735950 clinical trial?
This trial is open to participants of all sexes, aged 55 Years or older, studying Apathy in Dementia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06735950 currently recruiting?
Yes, NCT06735950 is actively recruiting participants. Contact the research team at klinedinst@umaryland.edu for enrollment information.
Where is the NCT06735950 trial being conducted?
This trial is being conducted at Catonsville, United States, Rockville, United States.
Who is sponsoring the NCT06735950 clinical trial?
NCT06735950 is sponsored by University of Maryland, Baltimore. The principal investigator is Jennifer Klinedinst, PhD, MPH, RN at University of Maryland, Baltimore. The trial plans to enroll 200 participants.